South-Easia's largest and most comprehensive Cell & Gene Group, specialising in umbilical cord HSCs, MSCs &iPSCs stem cell processing & banking, immune cell (NK, CIK, T-Cells) processing storage and applications, Clinical Trials (completed 3 with 6 in the pipelines) and other cutting-edge research involving EVs (Extracellular Vesicles) & Peptides.
Established Since
2002
Annual Revenue
$10-50 million
Employees
200
Business Attribute
Agent/ Distributor
Manufacturer
Business Nature
Biotech/ Diagnostics/ Pharmaceutical/ Regenerative Medicine/ Preventive Medicine
Company Highlights
1
Stem Cell Banking & Research Depth
Offers long-term banking of cord blood, cord MSCs, adult stem sources, plus carries out clinical trials (e.g. CAR-T, MSC therapies) in collaboration with universities & hospitals.
2
cGMP / AABB / PIC/S Certified Labs
CryoCord operates ISO Class 5 cleanrooms & BSL-2 GMP labs, fully licensed under Malaysia’s Ministry of Health – ensures top-tier safety and regulatory compliance.
3
Regional Leader & Trusted by Families
Thousands of families in Malaysia and SEA trust CryoCord for secure storage. Named Best Stem Cell Bank multiple years by Parenthood, BabyTalk, and other industry awards.
Market Presence
Cyberjaya, Malaysia, with nationwide offices in Penang, Johor, Ipoh, Kuching, Sibu, Kota Kinabalu.